Divya Samineni

A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

Franck Morschhauser, Pierre Feugier, Ian W. Flinn et al. · Blood · 2020 · 169 citations · Full text

Medicine, Hematology, Oncology +5

Cevostamab Monotherapy Continues to Show Clinically Meaningful Activity and Manageable Safety in Patients with Heavily Pre-Treated Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from an Ongoing Phase I Study

Suzanne Trudel, Adam D. Cohen, Amrita Krishnan et al. · Blood · 2021 · 161 citations

Medicine, Pharmacology, Pharmacotherapy +9

Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial

Andrew D. Zelenetz, Gilles Salles, Kylie D. Mason et al. · Blood · 2019 · 136 citations · Full text

Medicine, Oncology, Chemotherapy +9

Phase I Study of DMOT4039A, an Antibody–Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer

Colin D. Weekes, Laetitia E. Lamberts, Mitesh J. Borad et al. · Molecular Cancer Therapeutics · 2016 · 108 citations

Pharmacy, Oncology, Pharmacology +17

A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

Jeffrey M. Harris, Romeo Maciuca, Mary S. Bradley et al. · Respiratory Research · 2016 · 99 citations · Full text

Life Sciences, Immunology, Pharmacology +17